Circulating Tumor Cells Market Size, Share & Trends Analysis Report By Product

 This market research is a valuable tool for leaders seeking to align their strategies with the realities and opportunities in the circulating tumor cells industry.

 

 What Is The Current Outlook For The Circulating Tumor Cells Market By 2025?
 The circulating tumor cells market size has grown rapidly in recent years. It will grow from $11.9 billion in 2024 to $13.27 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to cancer incidence and prevalence, clinical utility in cancer staging, emergence of liquid biopsy, patient demand for minimally invasive tests, regulatory support for liquid biopsies, focus on early cancer detection.
 
 The circulating tumor cells market size is expected to see rapid growth in the next few years. It will grow to $21.38 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to point-of-care CTC testing, adoption of microfluidics, focus on rare cancer types, standardization of CTC assays, expansion of CTC-based clinical trials, economic and emerging market growth. Major trends in the forecast period include innovations in CTC isolation techniques, government funding for CTC research, advancements in CTC detection technologies, liquid biopsy for cancer monitoring, integration with single-cell analysis, technological convergence with artificial intelligence (AI).
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp
 
 What Are The Key Driving Factors For The Growth Of The Circulating Tumor Cells Market?
 The growing incidence of cancer is expected to propel the circulating tumor cells market growth going forward. Cancer refers to a disease in which a few body cells grow uncontrollably and spread to other parts. Circulating tumor cells are used to help in the early detection and diagnosis of cancer, and thus growing incidence of cancer propels the growth of the circulating tumor cells market. For instance, in January 2023, the American Cancer Society Journals, a US-based voluntary health organization, projected that 1,958,310 new cancer cases would be diagnosed, with 609,820 cancer-related deaths expected in the United States. Therefore, the growing incidence of cancer is driving the growth of the circulating tumor cells market. 
 
 Global Circulating Tumor Cells Market Report Segmentation
 The circulating tumor cells market covered in this report is segmented — 
 
 1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems
 2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis
 3) By Specimen: Blood, Bone Marrow, Other Body Fluids
 4) By Application: Clinical Or Liquid Biopsy, Research
 
 Subsegments:
 1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits 
 2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes 
 3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems 
 
 What Are The Key Trends And Market Opportunities In The Circulating Tumor Cells Sector?
 Product innovations are a key trend gaining popularity in the circulating tumor cells market. Major companies operating in the circulating tumor cells market are focused on developing innovative products to strengthen their position in the market. For instance, in June 2024, Bio-Rad Laboratories, Inc., a US-based medical laboratory, launched the Celselect Slides 2.0. It is designed to enhance the capture of rare cells and circulating tumor cells (CTCs), improving the accuracy and efficiency of cell analysis for clinical and research applications. 
 
 Who Are The Leading Players In The Circulating Tumor Cells Market?
 Major companies operating in the circulating tumor cells market include Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd. 
 
 View the full circulating tumor cells market report here:
 https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report
 
 Which Region Is Projected To Hold The Largest Market Share In The Global Circulating Tumor Cells Market By 2029?
 North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company